CLINICAL_TRIALS
trial_result
· 2020-04-15
Clinical Trial Update: Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis [Phase 3]
Summary
Extension study of ataluren in nonsense mutation cystic fibrosis participants has terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 3 | Status: TERMINATED | Results posted: 2020-04-15